CClinicalTrials.gg
Status unknownNCT05044858Updated Oct 1, 2021

Ultrasound-Guided Mid-Point Transverse Process to Pleura Block for Thoracotomy Incisions

An interventional study of Midpoint transverse process block group and Sham group in Pre-emptive, Postoperative Pain and Thoracotomy, sponsored by Tanta University. Status unknown at 1 site in Egypt. Open to participants aged 21 Years to 65 Years. Per ClinicalTrials.gov, last updated 2021-10-01.

Sponsored by Tanta University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2021), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
21 Years to 65 Years
Sex
All
01

Study summary

This study is designed to investigate the analgesic efficacy of pre-emptive ultrasound-guided midpoint transverse process to pleura (MTP) block for posterolateral thoracotomy in cardiothoracic surgeries.

Read the detailed description

Preemptive preoperative analgesia was first proposed, over the years it has been gradually regarded as an intervention given before incision, facilitating mobilization and functional rehabilitation after surgery, reducing postoperative opioid consumption, decreasing the incidence of adverse events and improving patient satisfaction.

The Mid Transverse Process to Pleura block, described by Costach et al. involves deposition of drug midway between the transverse process and pleura. Costach et al. postulated that the local anesthetic deposited at this point may reach the paravertebral space through several possible mechanisms, such as spread medially through the gap between the superior costotransverse ligament (SCTL) and vertebral bodies, through fenestrations in SCTL, and laterally through the internal intercostal membrane

02

Conditions studied

  • Pre-emptive
  • Postoperative Pain
  • Thoracotomy

Browse trials for

03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,137 are open to participants now.

This study's planned enrollment of 70 is close to the median of 75 across 4,341 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Tanta University is the lead sponsor of 963 studies on the registry; 304 are open to participants now.

Of its 16 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients aged 21- and65 years old
  • American Society of Anesthesiologists (ASA) II-III
  • Scheduled for posterolateral thoracotomy operation under general anesthesia

Exclusion criteria

Exclusion Criteria:

  • Patients with bleeding disorders,
  • Mental or cognitive dysfunction
  • History of chronic analgesic or drug abuse
  • Allergy to local anesthetics
  • Local infection at site of block
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Midpoint transverse process block group

    Patients will receive midpoint transverse process block after induction of general anesthesia and before surgical incision

    Procedure: Midpoint transverse process block group

  • Sham comparator
    Sham group

    Patients will receive general anesthesia and the same intervention steps will be performed i.e., the block under investigation but instead of local anesthetic a placebo (2ml normal saline) will be injected (sham block)

    Procedure: Sham group

Interventions

  • ProcedureMidpoint transverse process block group

    After marking the level of the incision by surgeon (commonly T5- T6) The patient will be situated in the lateral position, the block area will be sterilized with povidine-iodine, and high -frequency linear ultrasound probe will be placed oblique parasagittally 3 cm lateral to the spinous process at the level of skin incision. 100-mm short bevel echogenic needle (Contiplex, B.Braun, Germany) will be inserted in plane from cranial to caudal direction. The desired end point of the needle tip will be the midpoint of the line between the posterior border of transverse process and the pleura titrated bolus of 20 ml of 0.25% bupivacaine and dexamethazone 8 mg will be injected at the target site. At end of the surgery general anaesthesia will be stopped with reversal of muscle relaxation and awakening of patient

  • ProcedureSham group

    General anesthesia will be induced with the same protocol and MTP block will be done but with injection of placebo (2 ml normal saline) instead of local anesthetic . On arrival to the PACU postoperative Numerical Rating scale at rest and coughing will be recorded, analgesia will be maintained with intravenous paracetamol 1 g every 8 h and required additional rescue analgesia (morphine) at any time will be calculated.

06

What researchers measure

Primary outcomes

  1. The degree of Postoperative Pain

    Postoperative pain will be assessed by the Numerical Rating Scale (NRS;0 no pain while 10 is the maximum pain) at 0,4,8,12,18, 24 hours during rest and cough. If the (NRS) is 4 or more, morphine 3mg will be titrated until pain relief is achieved using a short interval between boluses

    Time frame: 24 hours postoperative

Secondary outcomes

  1. The amount of Postoperative morphine consumption

    Total morphine consumption at 24 hours after surgery

    Time frame: 24 hours Postoperative

  2. Time to the first rescue analgesia request

    Time till administration of first rescue analgesia

    Time frame: 24 hours Postoperative

  3. SpO2/FiO2 ratio

    SpO2/FiO2 ratio at 6,8,12 and 24h postoperatively

    Time frame: 24 hours Postoperative

07

Study locations

1 of 1 sites recruiting
  • Faculty of Medicine Tanta University
    Tanta, Elgarbia 31527, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The data will be available upon reasonable request from the principal investigator

Supporting information: Study protocol, Sap

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 1, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05044858
Lead sponsor
Tanta University
Responsible party
Heba Abdelhamid Mohamed (Resident of Anesthesiology and Surgical Intensive Care and Pain Medicine, Tanta University) — Principal investigator
First posted
Sep 16, 2021
Start date
Sep 24, 2021
Primary completion
Sep 20, 2022 (estimated)
Completion
Sep 20, 2022 (estimated)
Last update
Oct 1, 2021

Study contacts

Heba A. Mohamed, M.B.B.CH
Contact
Heba154537_pg@med.tanta.edu.eg
+20 111 505 4431

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion